Apart from missense variants that affect splicing, we only reported missense variants in the genes BRCA1, BRCA2 and TP53. Especially for genes associated with a moderate increased risk for breast cancer, several reports show that missense variants as a group are associated with lower breast cancer risks than protein truncating variants in the same genes. Here, BRCA2 is linked to breast carcinoma.